Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients

por Houssiau, Frédéric A
Publicado 2012

Management of Lupus Nephritis

por Tamirou, Farah, Houssiau, Frédéric A.
Publicado 2021

Prediction of prognosis and renal outcome in lupus nephritis

por Parodis, Ioannis, Tamirou, Farah, Houssiau, Frédéric A
Publicado 2020

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?

por Parodis, Ioannis, Tamirou, Farah, Houssiau, Frédéric A.
Publicado 2022

The “birth of death”: MRI step-by-step reveals the early appearance of a bone marrow infarct

por Barakat, Elie, Guischer, Nathalie, Houssiau, Frédéric, Lecouvet, Frederic E.
Publicado 2019

Absence of renal remission portends poor long-term kidney outcome in lupus nephritis

por Pirson, Valérie, Enfrein, Antoine, Houssiau, Frédéric A, Tamirou, Farah
Publicado 2021

Very Late-Onset Systemic Lupus Erythematosus as Unusual Cause of Reversible Functional and Cognitive Impairments in an Octogenarian Patient

por de Montjoye, Stéphanie, Boland, Benoit, Van Raemdonck, Jacqueline, Houssiau, Frédéric A
Publicado 2020

Worse long-term renal outcome of lupus nephritis patients of African descent living in Europe

por Enfrein, Antoine, Pirson, Valérie, Le Guern, Véronique, Karras, Adexandre, Tamirou, Farah, Costedoat-Chalumeau, Nathalie, Houssiau, Frederic
Publicado 2022

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial

por Tamirou, Farah, Lauwerys, Bernard R, Dall'Era, Maria, Mackay, Meggan, Rovin, Brad, Cervera, Ricard, Houssiau, Frédéric A
Publicado 2015

Effect of Belimumab on Preventing de novo Renal Lupus Flares

por Parodis, Ioannis, Lindblom, Julius, Cetrez, Nursen, Palazzo, Leonardo, Ala, Henri, Houssiau, Frédéric A., Sjöwall, Christopher, Rovin, Brad H.
Publicado 2023

High p16(INK4a), a marker of cellular senescence, is associated with renal injury, impairment and outcome in lupus nephritis

por Tilman, Gaëlle, Bouzin, Caroline, Aydin, Selda, Tamirou, Farah, Galant, Christine, Coulie, Pierre G, Houssiau, Frédéric, Lauwerys, Bernard, Limaye, Nisha
Publicado 2021

Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial

por Jayne, David, Rovin, Brad, Mysler, Eduardo, Furie, Richard, Houssiau, Frédéric, Trasieva, Teodora, Knagenhjelm, Jacob, Schwetje, Erik, Tang, Weifeng, Tummala, Raj, Lindholm, Catharina
Publicado 2023

Higher expression of TNFα-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line...

por De Groof, Aurélie, Ducreux, Julie, Humby, Frances, Nzeusseu Toukap, Adrien, Badot, Valérie, Pitzalis, Costantino, Houssiau, Frédéric A., Durez, Patrick, Lauwerys, Bernard R.
Publicado 2016

Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β

por Galant, Christine, Marchandise, Joel, Stoenoiu, Maria S, Ducreux, Julie, De Groof, Aurélie, Pirenne, Sophie, Van den Eynde, Benoit, Houssiau, Frédéric A, Lauwerys, Bernard R
Publicado 2019

Tapering of biological antirheumatic drugs in rheumatoid arthritis patients is achievable and cost-effective in daily clinical practice: data from the Brussels UCLouvain RA Cohort

por Dierckx, Stéphanie, Sokolova, Tatiana, Lauwerys, Bernard R., Avramovska, Aleksandra, de Bellefon, Laurent Meric, Toukap, Adrien Nzeusseu, Stoenoiu, Maria, Houssiau, Frédéric A., Durez, Patrick
Publicado 2020

Fasciae of the musculoskeletal system: normal anatomy and MR patterns of involvement in autoimmune diseases

por Kirchgesner, Thomas, Demondion, Xavier, Stoenoiu, Maria, Durez, Patrick, Nzeusseu Toukap, Adrien, Houssiau, Frédéric, Galant, Christine, Acid, Souad, Lecouvet, Frédéric, Malghem, Jacques, Vande Berg, Bruno
Publicado 2018

Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches

por Chairta, Paraskevi, Nicolaou, Paschalis, Sokratous, Kleitos, Galant, Christine, Houssiau, Frédéric, Oulas, Anastasis, Spyrou, George M., Alarcon-Riquelme, Marta E., Lauwerys, Bernard R., Christodoulou, Kyproula
Publicado 2020

Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis

por Badot, Valérie, Galant, Christine, Nzeusseu Toukap, Adrien, Theate, Ivan, Maudoux, Anne-Lise, Van den Eynde, Benoît J, Durez, Patrick, Houssiau, Frédéric A, Lauwerys, Bernard R
Publicado 2009

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-control...

por Wallace, Daniel J, Kalunian, Kenneth, Petri, Michelle A, Strand, Vibeke, Houssiau, Frederic A, Pike, Marilyn, Kilgallen, Brian, Bongardt, Sabine, Barry, Anna, Kelley, Lexy, Gordon, Caroline
Publicado 2014

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints

por Almaani, Salem, Bhatt, Udayan, Arriens, Cristina, Bonfa, Eloisa, Dall’Era, Maria, Houssiau, Frederic, Kalunian, Kenneth, Mackay, Megan, Sanchez-Guerrero, Jorge, Solomons, Neil, Rovin, Brad H.
Publicado 2020